Clinical trials: sponsored by Almirall, S.A.
Healthy Volunteers
A Study of LAD106 in Healthy Adult Participants
The main aim of this study is to assess the safety, tolerability, pharmacokinetics (PK), immunogenicity and pharmacodynamics (PD) of single ascending doses of LAD106 (Part A) and multiple ascending doses of LAD106 (Part B) in…
- Trial name
- NCT07471932
- Testing
- LAD106, Lebrikizumab
- Where
- Netherlands
- Volunteers
- 93 people, healthy volunteers welcome
- Sponsor
- Almirall, S.A.
Healthy Volunteers
A Single and Multiple Ascending Dose Study of LAD603 in Healthy Subjects
The purpose of the study is to evaluate the safety, tolerability, pharmacokinetics (PK), and immunogenicity of single and multiple ascending doses of LAD603 in healthy adult participants in both Part 1 and 2.
- Trial name
- NCT06200597
- Testing
- LAD603
- Where
- United States
- Volunteers
- 92 people, healthy volunteers welcome
- Sponsor
- Almirall, S.A.
Healthy Volunteers, Autoimmune Disease
Single and Multiple Ascending Dose Study in Healthy Participants and Participants With an Autoimmune Disease
The main purpose of this study is to to evaluate the safety, tolerability, pharmacokinetics (PK), pharmacodynamics (PD), immunogenicity of LAD191 in healthy adults and in adults with an autoimmune disease.
- Trial name
- NCT06488209
- Testing
- LAD191
- Where
- 3 sites in United States
- Volunteers
- 69 people, healthy volunteers welcome
- Sponsor
- Almirall, S.A.
Plaque Psoriasis
A Study to Assess Patient-Reported Wellbeing Using Tildrakizumab in a Live Setting
The main purpose of this study to investigate the relationship between clinical symptoms and quality of life (QoL) in participants who receive Tildrakizumab in the frame of clinical routine for the treatment of moderate to severe…
- Trial name
- NCT06488170
- Testing
- Tildrakizumab
- Where
- 7 sites in Czechia
- Volunteers
- 42 people, healthy volunteers welcome
- Sponsor
- Almirall, S.A.
Healthy Volunteers
Phototoxicity Test of Dapsone Gel in Healthy Volunteers
This study will evaluate the potential of dapsone gel and its vehicle to cause a phototoxic reaction following irradiation of the skin under controlled conditions.
- Trial name
- NCT02108483
- Testing
- dapsone gel, dapsone gel vehicle
- Where
- United States
- Volunteers
- 33 people, healthy volunteers welcome
- Sponsor
- Almirall, S.A.
Healthy Volunteers
Dermal Tolerability of Dapsone Gel in Healthy Volunteers
This study will determine the cumulative irritation potential and sensitization potential of dapsone gel and vehicle after repeat applications on the skin of healthy volunteers.
- Trial name
- NCT02117752
- Testing
- dapsone gel, dapsone gel vehicle, sodium lauryl sulfate
- Where
- United States
- Volunteers
- 237 people, healthy volunteers welcome
- Sponsor
- Almirall, S.A.
Healthy Volunteers
Photoallergy Potential of Dapsone Gel in Healthy Volunteers
This study will evaluate the potential of dapsone gel and its vehicle to cause a photoallergic reaction after repeated application and irradiation to the skin of healthy volunteers under controlled conditions.
- Trial name
- NCT02117739
- Testing
- dapsone gel, dapsone gel vehicle
- Where
- United States
- Volunteers
- 58 people, healthy volunteers welcome
- Sponsor
- Almirall, S.A.
Psoriasis
Study of the Effects of the Organism on Monomethyl Fumarate (MMF) After the Administration of LAS41008
The purpose of this study is to determine how the organism affects MMF (metabolite of dimethyl fumarate [DMF]) after single oral dose administration of LAS41008 120 mg gastroresistant tablet and Fumaderm® 120 mg gastro-resistant…
- Trial name
- LAS41008 (NCT02955693)
- Testing
- LAS41008 120 mg / Fumaderm® 120 mg
- Where
- United Kingdom
- Volunteers
- 32 people, healthy volunteers welcome
- Sponsor
- Almirall, S.A.